Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer’s Disease
Katarzyna Grychowska, Grzegorz Satała, Tomasz Kos, et al.
ACS Chemical Neuroscience (2016) Vol. 7, Iss. 7, pp. 972-983
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Synthesis of novel sulphonamide derivatives from tunable quinolines with computational studies
Nagesh Dhanaji Chavan, S. Sarveswari, V. Vijayakumar
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Additive-Free Three-Component Synthesis of Spiro-isoxazolidine-oxindoles Employing Trifluorodiazoethane
Ekta Gupta, Sindoori R. Nair, Ruchir Kant, et al.
The Journal of Organic Chemistry (2018) Vol. 83, Iss. 23, pp. 14811-14819
Closed Access | Times Cited: 28
Challenges Arising from Continuous‐Flow Olefin Metathesis
Antonio Del Vecchio, Harry R. Smallman, Jennifer Morvan, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 47
Open Access | Times Cited: 15
The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats
Nazarine Mokhtar, Marcin Drop, Florian Jacquot, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 364-364
Open Access | Times Cited: 9
Trifluoromethylnitrone: A Versatile Building Block for Synthesizing Trifluoromethyl-Containing Heterocyclic Compounds
Mohd Abdulla, Mohd Kamil Hussain, Shakir Ahamad
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 26, pp. 5242-5256
Closed Access | Times Cited: 3
Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation
Hugo R. Arias, Laura Micheli, Deborah Rudin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116867-116867
Open Access | Times Cited: 3
Enal-Azomethine Ylides: Application to the Synthesis of Functionalized Pyrroles
Pratap Kumar Mandal, Sandeep Patel, Sreenivas Katukojvala
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 28, pp. 5734-5738
Closed Access | Times Cited: 3
Palladium catalyzed Carbon-Carbon bond formation on Tunable Quinolines with DFT Study
Nagesh Dhanaji Chavan, V. Vijayakumar
Journal of Molecular Structure (2024) Vol. 1321, pp. 139739-139739
Closed Access | Times Cited: 3
5-HT6 receptor agonist and memory-enhancing properties of hypidone hydrochloride (YL-0919), a novel 5-HT1A receptor partial agonist and SSRI
Xiaofei Chen, Zengliang Jin, Ying Gong, et al.
Neuropharmacology (2018) Vol. 138, pp. 1-9
Closed Access | Times Cited: 24
Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6
Wesam Ali, Małgorzata Więcek, Dorota Łażewska, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 740-751
Closed Access | Times Cited: 24
Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro
Annamaria Lubelska, Gniewomir Latacz, Magdalena Jastrzębska‐Więsek, et al.
Molecules (2019) Vol. 24, Iss. 24, pp. 4472-4472
Open Access | Times Cited: 23
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
Vittorio Canale, Katarzyna Grychowska, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112765-112765
Open Access | Times Cited: 22
Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States
David Vanda, Vittorio Canale, Séverine Chaumont‐Dubel, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 2, pp. 1180-1196
Closed Access | Times Cited: 20
Continuous flow ring-closing metathesis, an environmentally-friendly route to 2,5-dihydro-1H-pyrrole-3-carboxylates
Marcin Drop, Xavier Bantreil, Katarzyna Grychowska, et al.
Green Chemistry (2017) Vol. 19, Iss. 7, pp. 1647-1652
Open Access | Times Cited: 24
2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design
Adam S. Hogendorf, Agata Hogendorf, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2019) Vol. 179, pp. 1-15
Closed Access | Times Cited: 21
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties
Paweł Zajdel, Katarzyna Grychowska, Szczepan Mogilski, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13279-13298
Open Access | Times Cited: 17
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines
Katarzyna Grychowska, Agnieszka Olejarz‐Maciej, Klaudia Blicharz, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114329-114329
Open Access | Times Cited: 12
1-(Arylsulfonyl-isoindol-2-yl)piperazines as 5-HT6R Antagonists: Mechanochemical Synthesis, In Vitro Pharmacological Properties and Glioprotective Activity
Vittorio Canale, Wojciech Trybała, Séverine Chaumont‐Dubel, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 12-12
Open Access | Times Cited: 12
5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives
Marcin Drop, Paulina Koczurkiewicz, Ophélie Bento, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116615-116615
Open Access | Times Cited: 2
Current development in sulfonamide derivatives to enable CNS-drug discovery
Klaudia Blicharz-Futera, Michał Kamiński, Katarzyna Grychowska, et al.
Bioorganic Chemistry (2024) Vol. 156, pp. 108076-108076
Closed Access | Times Cited: 2
Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury
Veronica Costiniti, Iolanda Spera, Roberta Menabò, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 9, pp. 3050-3059
Closed Access | Times Cited: 20
Synergetic copper/zinc catalysis: synthesis of aryl/heteroaryl-fused 1H-pyrrolo[3,2-c]pyridines
Gayyur, Shivani Choudhary, Ruchir Kant, et al.
Chemical Communications (2022) Vol. 58, Iss. 12, pp. 1974-1977
Closed Access | Times Cited: 11
Spatiotemporal dynamics of 5-HT6 receptor ciliary localization during mouse brain development
Vincent Dupuy, Matthieu Prieur, Anne Pizzoccaro, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105949-105949
Open Access | Times Cited: 11
Synthesis of new antiproliferative 1,3,4-substituted-pyrrolo[3,2-c]quinoline derivatives, biological and in silico insights
Francesco Mingoia, Caterina Di Sano, Claudia D’Anna, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115537-115537
Open Access | Times Cited: 6
Copper(II)-Catalyzed (3+2) Cycloaddition of 2H-Azirines to Six-Membered Cyclic Enols as a Route to Pyrrolo[3,2-c]quinolone, Chromeno[3,4-b]pyrrole, and Naphtho[1,8-ef]indole Scaffolds
Pavel А. Sakharov, Николай В. Ростовский, Alexander F. Khlebnikov, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5681-5681
Open Access | Times Cited: 10

Scroll to top